No Data
No Data
Not Many Are Piling Into Qingdao Baheal Medical INC. (SZSE:301015) Stock Yet As It Plummets 25%
Qingdao Baheal Medical INC. (SZSE:301015) shareholders that were waiting for something to happen have been dealt a blow with a 25% share price drop in the last month. The drop over the last 30 days
On July 3rd, 407 million restricted shares for Baiyang Pharmaceutical (301015.SZ) will be listed for trading.
According to the announcement of Baiyang Medicine (301015.SZ), before the company's initial public offering, the number of shares released prior to the lifting of restrictions amounted to 407 million shares, accounting for 77.38% of the company's total share capital. The date of listing is July 3, 2024 (Wednesday).
Qingdao Baheal Medical INC.'s (SZSE:301015) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
It is hard to get excited after looking at Qingdao Baheal Medical's (SZSE:301015) recent performance, when its stock has declined 25% over the past three months. However, stock prices are usually dr
Baiyang Pharmaceutical (301015.SZ) plans to pay 7.62 yuan for 10 shares to be deducted from interest on May 29
Baiyang Pharmaceutical (301015.SZ) announced that the company's 2023 equity distribution plan: every 10 shares to all shareholders...
Qingdao Baheal Medical (SZSE:301015) Looks To Prolong Its Impressive Returns
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Ideally, a business will show two trends; firstly a growing retur
Baiyang Pharmaceutical (301015.SZ): Proposed acquisition of shares in Baiyang Pharmaceutical, Baiyang Investment, Baiyang Yiren and Baiyang Kanghe
Gelonghui, May 20, 丨 Baiyang Pharmaceutical (301015.SZ) announced that the company plans to acquire 60.199% of the shares of Shanghai Baiyang Pharmaceutical Co., Ltd. (“Baiyang Pharmaceutical”) in cash. The transaction uses the evaluation report issued by the asset evaluation agency as the pricing reference. The specific arrangements are as follows: (1) Acquire Baiyang Pharmaceutical Group Co., Ltd. (hereinafter referred to as “Baiyang Group”) for 494.1851 million yuan (hereinafter referred to as “Baiyang Group”) holds 100.000% of the shares of Qingdao Baiyang Investment Group Co., Ltd. (hereinafter referred to as “Baiyang Investment”); (2) 88,86.6 million yuan The acquisition of Baiyang Group's holdings in Qingdao 100
No Data